A combined antitumor strategy of separately transduced mesenchymal stem cells with soluble TRAIL and IFNβ produces a synergistic activity in the reduction of lymphoma and mice survival enlargement Mol Med Rep. 2022. doi: 10.3892/mmr.2022.12722. IF: 3.423